The anti-tumor effects of cordycepin-loaded liposomes on the growth of hepatoma 22 tumors in mice and human hepatoma BEL-7402 cells in culture

Controlled and Targeted Drug Delivery by a UV-responsive Liposome for Overcoming Chemo-resistance in Non-Hodgkin Lymphoma

(2015) Huafei Li et al.   Chemical Biology & Drug Design

Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: Segregation of genotypes with specific ethnicities

(2015) Stuart P. Adams et al.   CLINICAL IMMUNOLOGY

Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation

(2015) Steven J Edwards et al.   HEALTH TECHNOLOGY ASSESSMENT

Liposomes as nanomedical devices

(2015) Giuseppina Bozzuto et al.   International Journal of Nanomedicine

Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model

(2015) Amin Reza Nikpoor et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis

(2015) Kazuki Nakamura et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Modulatory effect of iron chelators on adenosine deaminase activity and gene expression in Trichomonas vaginalis

(2015) Muriel Primon-Barros et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Toxicity evaluation of cordycepin and its delivery system for sustained in vitro anti-lung cancer activity

(2015) Pornanong Aramwit et al.   Nanoscale Research Letters

Nanopharmaceutics: Phytochemical-Based Controlled or Sustained Drug-Delivery Systems for Cancer Treatment

(2014) Roubeena Jeetah et al.   Journal of Biomedical Nanotechnology

5-Fluorouracil-loaded PLA/PLGA PEG–PPG–PEG polymeric nanoparticles: formulation,in vitrocharacterization and cell culture studies

(2013) Harika Öcal et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Structure–Activity Relationships of Synthetic Cordycepin Analogues as Experimental Therapeutics for African Trypanosomiasis

(2013) Suman K. Vodnala et al.   JOURNAL OF MEDICINAL CHEMISTRY

Cordycepin: A bioactive metabolite with therapeutic potential

(2013) Hardeep S. Tuli et al.   LIFE SCIENCES

Anticancer Drugs in Liposomal Nanodevices: A Target Delivery for a Targeted Therapy

(2012) Giorgia Urbinati et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Altered plasma and brain disposition of isopropylidene shikimic acid liposome in rats and the brain protection in cerebral ischemia–reperfusion

(2012) Changhai Qu et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Ras/ERK1 pathway regulation of p27KIP1-mediated G1-phase cell-cycle arrest in cordycepin-induced inhibition of the proliferation of vascular smooth muscle cells

(2012) Su-Mi Jung et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Susceptibility of Trypanosoma evansi to cordycepin

(2011) Aleksandro S. Da Silva et al.   BIOMEDICINE & PHARMACOTHERAPY

Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol

(2011) Xin-Yi Lu et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Ammonium sulfate gradient loading of brucine into liposomes: effect of phospholipid composition on entrapment efficiency and physicochemical properties in vitro

(2010) Jun Chen et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Cordycepin Induces Apoptosis of CGTH W-2 Thyroid Carcinoma Cells through the Calcium−Calpain−Caspase 7-PARP Pathway

(2010) Ying Chen et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells

(2009) Se-Jung Lee et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Preparation and evaluation of lyophilized liposome-encapsulated bufadienolides

(2009) Fang Li et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Proteomic detection of changes in protein expression induced by cordycepin in human hepatocellular carcinoma BEL-7402 cells

(2009) P. Shi et al.   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies

(2008) Jared N Silver et al.   PHARMACOGENOMICS